Clinical Trials Directory

Trials / Completed

CompletedNCT03959137

BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium

BEPACT Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium: A Cross-sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
215 (actual)
Sponsor
MSD Belgium BVBA · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The treatment landscape of metastatic non small cell lung cancer (NSCLC) is rapidly evolving. There are new diagnostic and treatment options available in the coming months and years. New combination treatments will give different solutions to pneumo-oncologists who might be guided by certain patient and tumor characteristics. The link between patient and tumor characteristics in untreated stage IV non small cell lung cancer (NSCLC) patients and systemic treatment needs further investigation, allowing the identification of possible treatment issues, data gaps and/or areas of improvement.

Detailed description

This is a multicenter, non-interventional, cross-sectional study. Consecutive patients with metastatic stage IV non small cell lung cancer (NSCLC) selected for systemic treatment or best supportive care will be included in the trial at the time the patient signed the informed consent form (ICF). Patients that were selected for systemic treatment, should have received at least their first dose and a maximum of one cycle of the same treatment. The pneumo-oncologist that treats the patient will fill in the CRF, indicating the systemic treatment option and the link with the variable categories that impacted the choice for a systemic treatment option.

Conditions

Interventions

TypeNameDescription
OTHERNone - Common practiceNone - Common practice

Timeline

Start date
2019-06-03
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2019-05-22
Last updated
2021-09-09
Results posted
2021-09-09

Locations

21 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03959137. Inclusion in this directory is not an endorsement.